ReviewFrontiers in public health2026
The impact of e-cigarette exposure on metabolic function: a narrative review.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electronic cigarettes (e-cigarettes) have rapidly emerged as a popular alternative to conventional tobacco smoking, contributing to a substantial rise in their global use over the past decade. Although marketed as a safer, combustion-free method of nicotine delivery, increasing evidence suggests that e-cigarette exposure may adversely affect metabolic health. This literature review evaluates current evidence regarding the impact of e-cigarette use on the metabolic system. Relevant studies published until 2026 were identified through searches of databases including PubMed, Embase, CINAHL, and reports from the World Health Organization. This narrative review incorporates findings from both human and animal studies examining the metabolic consequences of e-cigarette exposure. Current evidence suggests that nicotine and other aerosol constituents may contribute to metabolic dysregulation through oxidative stress, inflammation, mitochondrial dysfunction, and altered cellular signaling pathways. Several studies have demonstrated associations between e-cigarette use and obesity-related outcomes, including increased body mass index and adipose tissue dysfunction. Evidence has also linked e-cigarette exposure to insulin resistance, impaired glucose metabolism, elevated HbA1c levels, reduced antioxidant activity, and increased expression of glycogen synthase kinase-3 beta (GSK3β), a pathway implicated in the development of prediabetes. Additionally, broader components of metabolic syndrome, including hypertension, dyslipidemia, endothelial dysfunction, and cardiovascular risk factors, have been explored in the literature. While the findings collectively suggest a potential relationship between e-cigarette use and adverse metabolic outcomes, the current body of evidence remains limited by the predominance of cross-sectional and short-term studies. Further longitudinal, clinical, and mechanistic research is necessary to better establish causality and clarify the long-term metabolic effects of e-cigarette use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.